V
Vicente Pintado
Researcher at University of Alcalá
Publications - 92
Citations - 5403
Vicente Pintado is an academic researcher from University of Alcalá. The author has contributed to research in topics: Methicillin-resistant Staphylococcus aureus & Retrospective cohort study. The author has an hindex of 38, co-authored 86 publications receiving 4588 citations. Previous affiliations of Vicente Pintado include Hospital General Universitario Gregorio Marañón.
Papers
More filters
Journal ArticleDOI
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of hiv-1 protease
Sven A. Danner,Andrew Carr,John M. Leonard,Leah M. Lehman,Francesc Gudiol,Juan Alberto Gonzáles,Antonio Raventos,Rafael Rubio,Emilio Bouza,Vicente Pintado,Antonio Gil Aguado,J. Lomas,Rafael Delgado,Jan C. C. Borleffs,A. Hsu,Joaquin Mario Valdes,Charles A. Boucher,David A. Cooper +17 more
TL;DR: In this short-term study, ritonavir was well tolerated and had potent activity against HIV-1, but its clinical benefits remain to be established.
Journal ArticleDOI
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belén Gutiérrez-Gutiérrez,Elena Salamanca,Marina de Cueto,Po-Ren Hsueh,Pierluigi Viale,José Ramón Paño-Pardo,Mario Venditti,Mario Tumbarello,George L. Daikos,Rafael Cantón,Yohei Doi,Felipe Francisco Tuon,Ilias Karaiskos,Elena Pérez-Nadales,Mitchell J. Schwaber,Mitchell J. Schwaber,Özlem Kurt Azap,Maria Souli,Emmanuel Roilides,Spyros Pournaras,Murat Akova,Federico Perez,Joaquín Bermejo,Antonio Oliver,Manel Almela,Warren Lowman,Benito Almirante,Robert A. Bonomo,Robert A. Bonomo,Yehuda Carmeli,Yehuda Carmeli,David L. Paterson,Álvaro Pascual,Álvaro Pascual,Jesús Rodríguez-Baño,Jesús Rodríguez-Baño,M.D. del Toro,Jorge Galvez,Marco Falcone,Alessandro Russo,Helen Giamarellou,Enrico Maria Trecarichi,Angela Raffaella Losito,E. García-Vázquez,Alicia Hernandez,J. Gómez,Germán Bou,Elias Iosifidis,N. Prim,Ferran Navarro,Beatriz Mirelis,Anna Skiada,Julia Origüen,R. San Juan,Mario Fernández-Ruiz,Nieves Larrosa,Mireia Puig-Asensio,José Miguel Cisneros,José Molina,V. González,V. Rucci,E. Ruiz de Gopegui,C. I. Marinescu,Luis Martínez-Martínez,M.C. Fariñas,M. E. Cano,Mónica Gozalo,Marta Mora-Rillo,C. Navarro-San Francisco,Carmen Peña,Silvia Gómez-Zorrilla,Fe Tubau,Athanassios Tsakris,O. Zarkotou,Anastasia Antoniadou,Garyphallia Poulakou,Johann D. D. Pitout,Deepali Virmani,J. Torre-Cisneros,Julia Guzmán-Puche,Ö. Helvaci,A. O. Sahin,Vicente Pintado,Patricia Cordero Ruiz,Michele Bartoletti,Maddalena Giannella,Evelina Tacconelli,F. Riemenschneider,Esther Calbo,Cristina Badia,M. Xercavins,Oriol Gasch,D. Fontanals,E. Jové +93 more
TL;DR: Patients with BSIs due to CPE should receive active therapy as soon as they are diagnosed, and monotherapy should be considered for those in the low-mortality-score stratum.
Journal ArticleDOI
A Large Multicenter Study of Methicillin–Susceptible and Methicillin–Resistant Staphylococcus aureus Prosthetic Joint Infections Managed With Implant Retention
Jaime Lora-Tamayo,Oscar Murillo,José Antonio Iribarren,Alex Soriano,Mar Sánchez-Somolinos,Josu Miren Baraia-Etxaburu,Alicia Rico,Julián Palomino,Dolors Rodríguez-Pardo,Juan Pablo Horcajada,N. Benito,Alberto Bahamonde,A. Granados,María Dolores del Toro,Javier Cobo,Melchor Riera,Antonio Ramos,Alfredo Jover-Sáenz,Javier Ariza,G. Euba,Xavier Cabo,Salvador Pedrero,Miguel Ángel Goenaga,Maitane Elola,Enrique Moreno,Sebastián García-Ramiro,J.C. Martínez-Pastor,Eduard Tornero,Juan M. García-Lechuz,Mercedes Marín,Manuel Villanueva,Iñigo López,Ramón Cisterna,Juan Miguel Santamaría,M. Gomez,Andres Puente,Pedro Cano,Carlos Pigrau,Roger Sordé,Xavier Flores,Luisa Sorlí,Paula González-Miguez,Lluís Puig,María Franco,Marcos Jordán,Pere Coll,Juan Amador-Mellado,Carlos Fuster-Foz,Luis García-Paíno,Isabel Nieto,Miguel A. Muniain,Ana-Isabel Suárez,María Antonia Maseguer,Eduardo Garagorri,Vicente Pintado,Carmen Marinescu,Antonio Ramírez,Elena Múñez,Teresa Álvarez,Rodrigo García,Fernando Barcenilla,Laura Iogna Prat,Ferran Pérez +62 more
TL;DR: The use of rifampin may have contributed to homogenizing MSSA and MRSA prognoses, although the specific rifampsin combinations may have had different efficacies.
Journal ArticleDOI
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort.
Pilar Vizcarra,María J Pérez-Elías,Carmen Quereda,Ana Moreno,Maria Jesús Vivancos,Fernando Dronda,Jose L Casado,Santiago Moreno,Maria Jesús Pérez-Elías,Jesús Fortún,Enrique Navas,Santos del Campo,Rogelio López-Vélez,Javier Cobo Reinoso,José L. Casado,Franceca Norman,Pilar Martín-Dávila,José Hermida,José Antonio Pérez Molina,Begoña Monge,Vicente Pintado,Sergio Serrano-Villar,Matilde Sánchez-Conde,Sandra Chamorro,Rosa Escudero,Francesca Gioia,Belén Comeche,Clara Crespillo,Sabina Herrera,Raquel Ron,Javier Martínez-Sanz,Mario Pons-Guillén,María J Vivancos +32 more
TL;DR: HIV-infected individuals with COVID-19 should not be considered to be protected from SARS-CoV-2 infection or to have lower risk of severe disease, and they should receive the same treatment approach applied to the general population.
Journal ArticleDOI
Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study.
TL;DR: Although leishmaniasis could contribute to death in a significant number of HIV-infected patients, it was the main cause of death in only a few of them and should be considered as an AIDS-defining disease.